<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03583853</url>
  </required_header>
  <id_info>
    <org_study_id>amkmm</org_study_id>
    <nct_id>NCT03583853</nct_id>
  </id_info>
  <brief_title>Autophagy in Systemic Lupus Erythematosus</brief_title>
  <official_title>Autophagy Genes and Interleukin-10 in Systemic Lupus Erythematosus Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic lupus erythematosus is systemic autoimmune disease characterized by a wide range of
      clinical manifestations, from skin and mucosal lesions to severe injuries in the central
      nervous system, kidneys and other organs. The presence of high titres of autoantibodies
      against nuclear components, immune complexes deposition, complement deficiency and
      lymphocytes infiltration in affected tissues, which causes tissue and organ damage are the
      main characteristics of the disease. Nowadays, many studies elucidate the essential role of
      autophagy in the occurrence, development and severity of systemic lupus erythematosus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autophagy is a highly conserved lysosome-mediated catabolic process. It can remove unwanted
      cytoplasmic components, such as long-lived and/or misfolded proteins, damaged organelles,
      playing an important role in maintaining cellular homeostasis and cell survival in stress
      conditions, such as nutrient deprivation and hypoxia.

      Recently, Autophagy is implicated in nearly all steps of both innate and adaptive immune
      responses, including neutrophil extracellular trap and inflammasome formation, pathogen
      recognition, lymphocyte and monocyte development and function, antigen processing and
      presentation, type I interferon production and inflammatory regulation, thus playing an
      important part in maintaining the balance of immune system.

      Autophagy is divided into three major types: macroautophagy, microautophagy, and
      chaperone-mediated autophagy, with macroautophagy being the most investigated and understood.
      Disturbances in autophagy have been implicated in chronic inflammatory diseases and several
      autoimmune diseases, including Systemic lupus erythematosus, multiple sclerosis, Crohn's
      disease and rheumatoid arthritis.

      Several regulatory factors that may play key roles in autophagy processes have been
      discovered in recent years, such as beclin1, which is the key regulatory factor in the
      autophagy startup process, microtubule-associated protein-light chain 3, autophagy-related
      gene 5, which are components of autophagosomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the expression of autophagy genes in systemic lupus erythematosus patients group and control group</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>the expression of autophagy genes will be measured by real time polymerase chain reaction</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <description>take 5 ml blood for isolation of peripheral blood mono-nuclear cells then extraction of Ribonucleic acid (RNA) to determine the expression of autophagy genes by real time polymerase chain reaction (real time PCR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>take 5 ml blood for isolation of peripheral blood mono-nuclear cells then extraction of RNA to determine the expression of autophagy genes real time polymerase chain reaction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>real time PCR</intervention_name>
    <description>real time PCR will be used for determination of expression of autophagy genes</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        SLE patients are evaluated according to the SLE disease activity index 2000 (SLEDAI) and
        classified into two groups, one having active disease and the other group with inactive
        disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who fulfilled at least four criteria of systemic lupus erythematosus
             according to American College of Rheumatology

        Exclusion Criteria:

          -  Pregnancy or lactation.

          -  coexistence of other autoimmune diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed Ali el-feky, prof</last_name>
    <phone>00201223971310</phone>
    <email>mohelfeky@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed Saad Badary, prof</last_name>
    <phone>00201000103328</phone>
    <email>Dtn_diatechnology@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Ciccacci C, Perricone C, Alessandri C, Latini A, Politi C, Delunardo F, Pierdominici M, Conti F, Novelli G, Ortona E, Borgiani P. Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes. Lupus. 2018 Aug;27(9):1464-1469. doi: 10.1177/0961203318776108. Epub 2018 May 14.</citation>
    <PMID>29759048</PMID>
  </reference>
  <reference>
    <citation>Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007 Nov;8(11):931-7. Review.</citation>
    <PMID>17712358</PMID>
  </reference>
  <reference>
    <citation>Zhang Y, Morgan MJ, Chen K, Choksi S, Liu ZG. Induction of autophagy is essential for monocyte-macrophage differentiation. Blood. 2012 Mar 22;119(12):2895-905. doi: 10.1182/blood-2011-08-372383. Epub 2012 Jan 5.</citation>
    <PMID>22223827</PMID>
  </reference>
  <reference>
    <citation>Dang J, Li J, Xin Q, Shan S, Bian X, Yuan Q, Liu N, Ma X, Li Y, Liu Q. Gene-gene interaction of ATG5, ATG7, BLK and BANK1 in systemic lupus erythematosus. Int J Rheum Dis. 2016 Dec;19(12):1284-1293. doi: 10.1111/1756-185X.12768. Epub 2015 Sep 30.</citation>
    <PMID>26420661</PMID>
  </reference>
  <reference>
    <citation>Zhu L, Wang H, Wu Y, He Z, Qin Y, Shen Q. The Autophagy Level Is Increased in the Synovial Tissues of Patients with Active Rheumatoid Arthritis and Is Correlated with Disease Severity. Mediators Inflamm. 2017;2017:7623145. doi: 10.1155/2017/7623145. Epub 2017 Feb 1.</citation>
    <PMID>28255205</PMID>
  </reference>
  <reference>
    <citation>Teruel M, Alarcón-Riquelme ME. The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned. J Autoimmun. 2016 Nov;74:161-175. doi: 10.1016/j.jaut.2016.08.001. Epub 2016 Aug 10. Review.</citation>
    <PMID>27522116</PMID>
  </reference>
  <reference>
    <citation>Zhou XJ, Lu XL, Lv JC, Yang HZ, Qin LX, Zhao MH, Su Y, Li ZG, Zhang H. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann Rheum Dis. 2011 Jul;70(7):1330-7. doi: 10.1136/ard.2010.140111.</citation>
    <PMID>21622776</PMID>
  </reference>
  <reference>
    <citation>Godsell J, Rudloff I, Kandane-Rathnayake R, Hoi A, Nold MF, Morand EF, Harris J. Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus. Sci Rep. 2016 Oct 6;6:34604. doi: 10.1038/srep34604.</citation>
    <PMID>27708376</PMID>
  </reference>
  <reference>
    <citation>López P, Alonso-Pérez E, Rodríguez-Carrio J, Suárez A. Influence of Atg5 mutation in SLE depends on functional IL-10 genotype. PLoS One. 2013 Oct 18;8(10):e78756. doi: 10.1371/journal.pone.0078756. eCollection 2013.</citation>
    <PMID>24205307</PMID>
  </reference>
  <reference>
    <citation>Ward MM, Marx AS, Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol. 2000 Mar;27(3):664-70.</citation>
    <PMID>10743805</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 22, 2018</study_first_submitted>
  <study_first_submitted_qc>July 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>July 11, 2018</last_update_submitted>
  <last_update_submitted_qc>July 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ayat Mostafa</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

